Accepted Abstract is a Sub-Study in RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial and Explores the TAMP™ Therapy Platform’s Potential to Increase Local Drug Potency and Reduce Systemic ...

Monterey Park unanimously banned data centers after residents organized around utility costs and infrastructure impacts, ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on promising new therapies in oncology ...

Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS Newswire / April ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...

Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their ...

The CEO of the Canadian Investment Regulatory Organization (CIRO) says the industry’s “data ecosystem,” including data ...

Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been ...

Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on it ...

Sleep duration may have a significant impact on cancer risk.Data presented at American Association for Cancer Research Annual Meeting showed individuals who slept less than 7 to 8 hours per night had ...

Why Terminology Confusion Still Undermines Modern Defense Cybersecurity discussions are filled with familiar language. Security teams talk about the latest threats and threat landscape, attack ...